Advantages:

To investigate the ischemic changes after intravitreal injection for treatment of ME with CRVO.

Methods:  

55 patients treated with anti-VEGF for ME with CRVO were included.

Take home message:

Intravitreal injection for ME with CRVO could induce ischemic changes in some cases. So these possibilities have to be notified to patients and close follow-up is necessary.